These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||
|
|
|
|||||||||||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|||||||||||||
|
|
|
|
|
|||||||||||
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
☒
|
Accelerated filer
|
☐
|
||||||||
| Non-accelerated filer |
☐
|
Smaller reporting company
|
|
||||||||
|
Emerging growth company
|
|
||||||||||
|
PAGE
|
||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (dollars in thousands, except share and per share data) |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Inventory write-down |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Research and development |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
||||||||||||||||||||||
| Interest |
|
|
|
|
||||||||||||||||||||||
| Asset impairment |
|
|
|
|
||||||||||||||||||||||
| Restructuring |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Earnings before income taxes |
|
|
|
|
||||||||||||||||||||||
| Income taxes |
|
|
|
|
||||||||||||||||||||||
| Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net earnings per share | ||||||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||
| Basic |
|
|
|
|
||||||||||||||||||||||
| Diluted |
|
|
|
|
||||||||||||||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (dollars in thousands) |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other comprehensive income (loss) ("OCI"), net of tax: | ||||||||||||||||||||||||||
| Foreign currency translation adjustment |
|
(
|
(
|
|
||||||||||||||||||||||
| Retirement liability adjustment |
|
|
|
|
||||||||||||||||||||||
| Change in accumulated loss on derivatives |
|
|
|
|
||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
(
|
|
||||||||||||||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||||||||||||||
| (dollars in thousands) |
March 29,
2025 |
September 28,
2024 |
||||||||||||
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Receivables, net |
|
|
||||||||||||
| Unbilled receivables |
|
|
||||||||||||
| Inventories, net |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||
| Operating lease right-of-use assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets, net |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued compensation |
|
|
||||||||||||
| Contract advances and progress billings |
|
|
||||||||||||
| Accrued liabilities and other |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term debt, excluding current installments |
|
|
||||||||||||
| Long-term pension and retirement obligations |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other long-term liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
| Shareholders’ equity | ||||||||||||||
| Common stock - Class A |
|
|
||||||||||||
| Common stock - Class B |
|
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
| Treasury shares |
(
|
(
|
||||||||||||
| Stock Employee Compensation Trust |
(
|
(
|
||||||||||||
| Supplemental Retirement Plan Trust |
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (dollars in thousands) |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| COMMON STOCK | ||||||||||||||||||||||||||
| Beginning and end of period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| ADDITIONAL PAID-IN CAPITAL | ||||||||||||||||||||||||||
| Beginning of period |
|
|
|
|
||||||||||||||||||||||
| Issuance of treasury shares |
|
|
|
|
||||||||||||||||||||||
| Equity-based compensation expense |
|
|
|
|
||||||||||||||||||||||
| Adjustment to market - SECT and SERP |
(
|
|
(
|
|
||||||||||||||||||||||
| End of period |
|
|
|
|
||||||||||||||||||||||
| RETAINED EARNINGS | ||||||||||||||||||||||||||
| Beginning of period |
|
|
|
|
||||||||||||||||||||||
| Net earnings |
|
|
|
|
||||||||||||||||||||||
|
Dividends
(1)
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
|
|
|
|
||||||||||||||||||||||
| TREASURY SHARES AT COST | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Class A and B shares issued related to compensation |
|
|
|
|
||||||||||||||||||||||
| Class A and B shares purchased |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Issuance of shares |
|
|
|
|
||||||||||||||||||||||
| Purchase of shares |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Adjustment to market |
|
(
|
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Adjustment to market |
|
(
|
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| ACCUMULATED OTHER COMPREHENSIVE LOSS | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Other comprehensive income (loss) |
|
(
|
(
|
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| (share data) |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| COMMON STOCK - CLASS A | ||||||||||||||||||||||||||
| Beginning of period |
|
|
|
|
||||||||||||||||||||||
| Conversion of Class B to Class A |
|
|
|
|
||||||||||||||||||||||
| End of period |
|
|
|
|
||||||||||||||||||||||
| COMMON STOCK - CLASS B | ||||||||||||||||||||||||||
| Beginning of period |
|
|
|
|
||||||||||||||||||||||
| Conversion of Class B to Class A |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
|
|
|
|
||||||||||||||||||||||
| TREASURY SHARES - CLASS A COMMON STOCK | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Class A shares issued related to compensation |
|
|
|
|
||||||||||||||||||||||
| Class A shares purchased |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| TREASURY SHARES - CLASS B COMMON STOCK | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Class B shares issued related to compensation |
|
|
|
|
||||||||||||||||||||||
| Class B shares purchased |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| SECT - CLASS A COMMON STOCK | ||||||||||||||||||||||||||
| Beginning and end of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| SECT - CLASS B COMMON STOCK | ||||||||||||||||||||||||||
| Beginning of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Issuance of shares |
|
|
|
|
||||||||||||||||||||||
| Purchase of shares |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| End of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| SERP - CLASS B COMMON STOCK | ||||||||||||||||||||||||||
| Beginning and end of period |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||||||||||||||
| Six Months Ended | ||||||||||||||
| (dollars in thousands) |
March 29,
2025 |
March 30,
2024 |
||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||
| Net earnings | $ |
|
$ |
|
||||||||||
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | ||||||||||||||
| Depreciation |
|
|
||||||||||||
| Amortization |
|
|
||||||||||||
| Deferred income taxes |
(
|
(
|
||||||||||||
| Equity-based compensation expense |
|
|
||||||||||||
| Asset impairment |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Changes in assets and liabilities providing (using) cash: | ||||||||||||||
| Receivables |
(
|
|
||||||||||||
| Unbilled receivables |
(
|
(
|
||||||||||||
| Inventories |
(
|
(
|
||||||||||||
| Accounts payable |
|
|
||||||||||||
| Contract advances and progress billings |
|
|
||||||||||||
| Accrued expenses |
(
|
|
||||||||||||
| Accrued income taxes |
(
|
|
||||||||||||
| Net pension and post retirement liabilities |
|
|
||||||||||||
| Other assets and liabilities |
(
|
(
|
||||||||||||
| Net cash provided (used) by operating activities |
(
|
|
||||||||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||
| Acquisitions of businesses, net of cash acquired |
|
(
|
||||||||||||
| Purchase of property, plant and equipment |
(
|
(
|
||||||||||||
| Net proceeds from businesses sold |
|
|
||||||||||||
| Other investing transactions |
(
|
(
|
||||||||||||
| Net cash provided (used) by investing activities |
(
|
(
|
||||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||
| Proceeds from revolving lines of credit |
|
|
||||||||||||
| Payments on revolving lines of credit |
(
|
(
|
||||||||||||
| Payments on finance lease obligations |
(
|
(
|
||||||||||||
| Payment of dividends |
(
|
(
|
||||||||||||
| Proceeds from sale of treasury stock |
|
|
||||||||||||
| Purchase of outstanding shares for treasury |
(
|
(
|
||||||||||||
| Proceeds from sale of stock held by SECT |
|
|
||||||||||||
| Purchase of stock held by SECT |
(
|
(
|
||||||||||||
| Other financing transactions |
(
|
|
||||||||||||
| Net cash provided (used) by financing activities |
|
|
||||||||||||
| Effect of exchange rate changes on cash |
(
|
|
||||||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash |
(
|
(
|
||||||||||||
|
Cash, cash equivalents and restricted cash at beginning of period
(1)
|
|
|
||||||||||||
| Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
||||||||||
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||||||||
| Treasury shares issued as compensation | $ |
|
$ |
|
||||||||||
| Assets acquired through lease financing |
|
|
||||||||||||
| See accompanying Notes to Consolidated Condensed Financial Statements. | ||||||||||||||
| Standard | Description | Financial Statement Effect or Other Significant Matters | ||||||||||||
|
ASU no. 2023-07
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
|
This standard requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources. The provisions of the standard are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendment requires retrospective application to all prior periods presented in the financial statements. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. | ||||||||||||
|
Planned date of adoption:
FY 2025 |
||||||||||||||
|
ASU no. 2023-09
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
|
This standard expands annual income tax disclosures to require specific categories in the rate reconciliation table to be disclosed using both percentages and reporting currency amounts and requires additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires disclosure of income taxes paid by jurisdiction. The provisions of the standard are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application is permitted. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. | ||||||||||||
|
Planned date of adoption:
FY 2026 |
||||||||||||||
|
ASU no. 2024-03
Income Statement -Reporting Comprehensive Income-Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses
|
This standard requires disclosure of specified information about certain cost and expenses at each interim and annual reporting period. This includes disclosure of the amounts of purchases of inventory, employee compensation, depreciation and intangible asset for each relevant expense caption on the income statement, as well as the total amount of selling expenses. Additionally, the amendments require disclosing a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The provisions of the standard are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to all prior periods presented in the financial statements. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. | ||||||||||||
|
Planned date of adoption:
FY 2028 |
||||||||||||||
|
March 29,
2025 |
September 28, 2024 | |||||||||||||
| Unbilled receivables | $ |
|
$ |
|
||||||||||
| Contract advances and progress billings |
|
|
||||||||||||
| Net contract assets | $ |
|
$ |
|
||||||||||
|
March 29,
2025 |
September 28,
2024 |
||||||||||||||||
| Accounts receivable | $ |
|
$ |
|
|||||||||||||
| Government assistance receivables |
|
|
|||||||||||||||
| Other |
|
|
|||||||||||||||
| Less allowance for credit losses |
(
|
(
|
|||||||||||||||
| Receivables, net | $ |
|
$ |
|
|||||||||||||
|
March 29,
2025 |
September 28,
2024 |
|||||||||||||
| Raw materials and purchased parts | $ |
|
$ |
|
||||||||||
| Work in progress |
|
|
||||||||||||
| Finished goods |
|
|
||||||||||||
| Inventories, net | $ |
|
$ |
|
||||||||||
|
March 29,
2025 |
September 28,
2024 |
|||||||||||||||||||
| Land | $ |
|
$ |
|
||||||||||||||||
| Buildings and improvements |
|
|
||||||||||||||||||
| Machinery and equipment |
|
|
||||||||||||||||||
| Computer equipment and software |
|
|
||||||||||||||||||
| Property, plant and equipment, at cost |
|
|
||||||||||||||||||
| Less accumulated depreciation and amortization |
(
|
(
|
||||||||||||||||||
| Property, plant and equipment, net | $ |
|
$ |
|
||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||
| Operating lease cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Finance lease cost: | ||||||||||||||
| Amortization of right-of-use assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Interest on lease liabilities |
|
|
|
|
||||||||||
| Total finance lease cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Six Months Ended | ||||||||
|
March 29,
2025 |
March 30,
2024 |
|||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||
| Operating cash flow for operating leases | $ |
|
$ |
|
||||
| Operating cash flow for finance leases |
|
|
||||||
| Financing cash flow for finance leases |
|
|
||||||
| Assets obtained in exchange for lease obligations: | ||||||||
| Operating leases | $ |
|
$ |
|
||||
| Finance leases |
|
|
||||||
|
March 29,
2025 |
September 28,
2024 |
|||||||
| Operating Leases: | ||||||||
| Operating lease right-of-use assets | $ |
|
$ |
|
||||
| Accrued liabilities and other | $ |
|
$ |
|
||||
| Other long-term liabilities |
|
|
||||||
| Total operating lease liabilities | $ |
|
$ |
|
||||
| Finance Leases: | ||||||||
| Property, plant, and equipment, at cost | $ |
|
$ |
|
||||
| Accumulated depreciation |
(
|
(
|
||||||
| Property, plant, and equipment, net | $ |
|
$ |
|
||||
| Accrued liabilities and other | $ |
|
$ |
|
||||
| Other long-term liabilities |
|
|
||||||
| Total finance lease liabilities | $ |
|
$ |
|
||||
| Weighted average remaining lease term in years: | ||||||||
| Operating leases |
|
|
||||||
| Finance leases |
|
|
||||||
| Weighted average discount rates: | ||||||||
| Operating leases |
|
% |
|
% | ||||
| Finance leases |
|
% |
|
% | ||||
| March 29, 2025 | ||||||||||||||
| Operating Leases | Finance Leases | |||||||||||||
| 2025 | $ |
|
$ |
|
||||||||||
| 2026 |
|
|
||||||||||||
| 2027 |
|
|
||||||||||||
| 2028 |
|
|
||||||||||||
| 2029 |
|
|
||||||||||||
| Thereafter |
|
|
||||||||||||
| Total lease payments |
|
|
||||||||||||
| Less: imputed interest |
(
|
(
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
|
Space and
Defense |
Military Aircraft | Commercial Aircraft | Industrial | Total | |||||||||||||
| Balance at September 28, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
| Foreign currency translation |
(
|
(
|
|
(
|
(
|
||||||||||||
| Balance at March 29, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
| March 29, 2025 | September 28, 2024 | |||||||||||||||||||||||||||||||
|
Weighted-
Average Life (years) |
Gross Carrying
Amount |
Accumulated
Amortization |
Gross Carrying
Amount |
Accumulated
Amortization |
||||||||||||||||||||||||||||
| Customer-related |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
| Technology-related |
|
|
(
|
|
(
|
|||||||||||||||||||||||||||
| Program-related |
|
|
(
|
|
(
|
|||||||||||||||||||||||||||
| Marketing-related |
|
|
(
|
|
(
|
|||||||||||||||||||||||||||
| Other |
|
|
(
|
|
(
|
|||||||||||||||||||||||||||
| Intangible assets |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||
| Acquired intangible asset amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | |||||||||||||
| Estimated future amortization of acquired intangible assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
|
March 29,
2025 |
September 28,
2024 |
||||||||||||||||||||||
| Moog Aircraft Service Asia | $ |
|
$ |
|
|||||||||||||||||||
| Suffolk Technologies Fund 1, L.P. |
|
|
|||||||||||||||||||||
| Net investment balance | $ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| Net gain (loss) | ||||||||||||||||||||||||||
| Equity method investments and joint ventures | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
March 29,
2025 |
September 28,
2024 |
|||||||||||||
| U.S. revolving credit facility | $ |
|
$ |
|
||||||||||
| SECT revolving credit facility |
|
|
||||||||||||
| Senior notes 4.25% |
|
|
||||||||||||
| Senior debt |
|
|
||||||||||||
| Less deferred debt issuance cost |
(
|
(
|
||||||||||||
| Long-term debt | $ |
|
$ |
|
||||||||||
|
March 29,
2025 |
September 28, 2024 | |||||||||||||
| Employee benefits | $ |
|
$ |
|
||||||||||
| Contract reserves |
|
|
||||||||||||
| Warranty accrual |
|
|
||||||||||||
| Accrued income taxes |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Other accrued liabilities | $ |
|
$ |
|
||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warranty accrual at beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warranties issued during current period |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjustments to pre-existing warranties |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reductions for settling warranties |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation |
|
(
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warranty accrual at end of period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| Statements of Earnings location |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||||
| Net gain (loss) | |||||||||||||||||||||||||||||
| Foreign currency contracts | Other | $ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||
| Balance Sheets location |
March 29,
2025 |
September 28,
2024 |
|||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||
| Foreign currency contracts | Other current assets | $ |
|
$ |
|
||||||||||||
| Foreign currency contracts | Other assets |
|
|
||||||||||||||
| Total asset derivatives | $ |
|
$ |
|
|||||||||||||
| Foreign currency contracts | Other long-term liabilities |
|
|
||||||||||||||
| Total liability derivatives | $ |
|
$ |
|
|||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||
| Foreign currency contracts | Other current assets | $ |
|
$ |
|
||||||||||||
| Foreign currency contracts | Accrued liabilities and other | $ |
|
$ |
|
||||||||||||
| Balance Sheets location |
March 29,
2025 |
September 28,
2024 |
||||||||||||||||||
| Foreign currency contracts | Other current assets | $ |
|
$ |
|
|||||||||||||||
| Foreign currency contracts | Other assets |
|
|
|||||||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||||||||
| Foreign currency contracts | Accrued liabilities and other | $ |
|
$ |
|
|||||||||||||||
| Foreign currency contracts | Other long-term liabilities |
|
|
|||||||||||||||||
| Acquisition contingent consideration | Accrued liabilities and other |
|
|
|||||||||||||||||
| Total liabilities | $ |
|
$ |
|
||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| Balance at beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Increase in discounted future cash flows recorded as interest expense |
|
|
|
|
||||||||||||||||||||||
| Increase in earn out provisions recorded as other expense |
|
|
|
|
||||||||||||||||||||||
| Settlements paid in cash |
(
|
|
(
|
|
||||||||||||||||||||||
| Balance at end of period | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Space and Defense | Military Aircraft | Commercial Aircraft | Industrial | Total | ||||||||||||||||
| Balance at September 28, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||
| Charged to expense - 2024 plan |
|
|
|
|
|
|||||||||||||||
| Charged to expense - 2023 plan |
|
|
|
|
|
|||||||||||||||
| Adjustments to provision |
|
|
|
(
|
(
|
|||||||||||||||
| Non-cash charges - 2024 plan |
(
|
|
|
(
|
(
|
|||||||||||||||
| Cash payments - 2024 plan |
(
|
(
|
(
|
(
|
(
|
|||||||||||||||
| Cash payments - 2023 plan |
|
|
|
(
|
(
|
|||||||||||||||
| Cash payments - 2022 plan |
|
|
|
(
|
(
|
|||||||||||||||
| Cash payments - 2020 plan |
|
|
|
(
|
(
|
|||||||||||||||
| Cash payments - 2018 plan |
|
|
|
(
|
(
|
|||||||||||||||
| Foreign currency translation |
|
|
|
(
|
(
|
|||||||||||||||
| Balance at March 29, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| U.S. defined contribution plans | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Non-U.S. defined contribution plans |
|
|
|
|
||||||||||||||||||||||
| Total expense for defined contribution plans | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| U.S. Plans | ||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Amortization of actuarial loss |
|
|
|
|
||||||||||||||||||||||
| Expense for U.S. defined benefit plans | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Non-U.S. Plans | ||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Amortization of prior service cost |
|
|
|
|
||||||||||||||||||||||
| Amortization of actuarial loss |
|
|
|
|
||||||||||||||||||||||
| Expense for non-U.S. defined benefit plans | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Accumulated foreign currency translation | Accumulated retirement liability | Accumulated gain (loss) on derivatives | Total | |||||||||||||||||||||||
| AOCIL at September 28, 2024 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| OCI before reclassifications |
(
|
|
|
(
|
||||||||||||||||||||||
| Amounts reclassified from AOCIL |
|
|
(
|
|
||||||||||||||||||||||
| OCI, net of tax |
(
|
|
|
(
|
||||||||||||||||||||||
| AOCIL at March 29, 2025 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
| Statements of Earnings location |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||||||||
| Retirement liability: | ||||||||||||||||||||||||||||||||
| Prior service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
| Actuarial losses |
|
|
|
|
||||||||||||||||||||||||||||
| Reclassification from AOCIL into earnings |
|
|
|
|
||||||||||||||||||||||||||||
| Tax effect |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||
| Net reclassification from AOCIL into earnings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
| Derivatives: | ||||||||||||||||||||||||||||||||
| Foreign currency contracts | Cost of sales | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Reclassification from AOCIL into earnings |
(
|
|
(
|
|
||||||||||||||||||||||||||||
| Tax effect |
|
(
|
|
(
|
||||||||||||||||||||||||||||
| Net reclassification from AOCIL into earnings | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
| Foreign currency translation: | ||||||||||||||||||||||||||||||||
| Business dispositions | Other | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
| Reclassification from AOCIL into earnings |
(
|
|
|
(
|
||||||||||||||||||||||||||||
| Tax effect |
|
|
|
|
||||||||||||||||||||||||||||
| Net reclassification from AOCIL into earnings | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| Foreign currency contracts | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
| Net gain (loss) |
|
(
|
|
|
||||||||||||||||||||||
| Tax effect |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Net deferral in AOCIL of derivatives | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| Basic weighted-average shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Dilutive effect of equity-based awards |
|
|
|
|
||||||||||||||||||||||
| Diluted weighted-average shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Anti-dilutive shares from equity-based awards |
|
|
|
|
||||||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| Market Type |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| Net sales: | ||||||||||||||||||||||||||
| Space | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Defense |
|
|
|
|
||||||||||||||||||||||
| Space and Defense |
|
|
|
|
||||||||||||||||||||||
| Original Equipment Manufacturers |
|
|
|
|
||||||||||||||||||||||
| Aftermarket |
|
|
|
|
||||||||||||||||||||||
| Military Aircraft |
|
|
|
|
||||||||||||||||||||||
| Original Equipment Manufacturers |
|
|
|
|
||||||||||||||||||||||
| Aftermarket |
|
|
|
|
||||||||||||||||||||||
| Commercial Aircraft |
|
|
|
|
||||||||||||||||||||||
| Energy |
|
|
|
|
||||||||||||||||||||||
| Industrial Automation |
|
|
|
|
||||||||||||||||||||||
| Simulation and Test |
|
|
|
|
||||||||||||||||||||||
| Medical |
|
|
|
|
||||||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| Customer Type |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| Net sales: | ||||||||||||||||||||||||||
| Commercial | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| U.S. Government (including OEM) |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Space and Defense |
|
|
|
|
||||||||||||||||||||||
| U.S. Government (including OEM) |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
|
Military Aircraft
|
|
|
|
|
||||||||||||||||||||||
| Commercial |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
|
Commercial Aircraft
|
|
|
|
|
||||||||||||||||||||||
| Commercial |
|
|
|
|
||||||||||||||||||||||
| U.S. Government (including OEM) |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||
| Commercial |
|
|
|
|
||||||||||||||||||||||
| U.S. Government (including OEM) |
|
|
|
|
||||||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
| Revenue Recognition Method |
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
||||||||||||||||||||||
| Net sales: | ||||||||||||||||||||||||||
| Over-time | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Point in time |
|
|
|
|
||||||||||||||||||||||
| Space and Defense |
|
|
|
|
||||||||||||||||||||||
| Over-time |
|
|
|
|
||||||||||||||||||||||
| Point in time |
|
|
|
|
||||||||||||||||||||||
| Military Aircraft |
|
|
|
|
||||||||||||||||||||||
| Over-time |
|
|
|
|
||||||||||||||||||||||
| Point in time |
|
|
|
|
||||||||||||||||||||||
| Commercial Aircraft |
|
|
|
|
||||||||||||||||||||||
| Over-time |
|
|
|
|
||||||||||||||||||||||
| Point in time |
|
|
|
|
||||||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||
| Over-time |
|
|
|
|
||||||||||||||||||||||
| Point in time |
|
|
|
|
||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||
|
March 29,
2025 |
March 30,
2024 |
March 29,
2025 |
March 30,
2024 |
|||||||||||||||||||||||
| Operating profit: | ||||||||||||||||||||||||||
| Space and Defense | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Military Aircraft |
|
|
|
|
||||||||||||||||||||||
| Commercial Aircraft |
|
|
|
|
||||||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||
| Total operating profit |
|
|
|
|
||||||||||||||||||||||
| Deductions from operating profit: | ||||||||||||||||||||||||||
| Interest expense |
|
|
|
|
||||||||||||||||||||||
| Equity-based compensation expense |
|
|
|
|
||||||||||||||||||||||
| Non-service pension expense |
|
|
|
|
||||||||||||||||||||||
| Corporate and other expenses, net |
|
|
|
|
||||||||||||||||||||||
| Earnings before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| CONSOLIDATED RESULTS OF OPERATIONS | |||||||||||||||||||||||||||||
|
Three Months Ended
|
Six Months Ended | ||||||||||||||||||||||||||||
| (dollars and shares in millions, except per share data) | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | |||||||||||||||||||||
| Net sales | $ | 935 | $ | 930 | $ | 5 | — | % | $ | 1,845 | $ | 1,787 | $ | 58 | 3 | % | |||||||||||||
| Gross margin | 27.4 | % | 28.7 | % | 27.0 | % | 28.0 | % | |||||||||||||||||||||
| Research and development expenses | 24 | 28 | (4) | (14 | %) | 48 | 59 | (11) | (18 | %) | |||||||||||||||||||
| Selling, general and administrative expenses as a percentage of sales | 14.2 | % | 13.4 | % | 14.1 | % | 13.6 | % | |||||||||||||||||||||
| Interest expense | 20 | 18 | 2 | 9 | % | 37 | 35 | 2 | 5 | % | |||||||||||||||||||
| Asset impairment | — | 7 | (7) | N/M | — | 7 | (7) | N/M | |||||||||||||||||||||
| Restructuring expense | 2 | 7 | (4) | N/M | 6 | 9 | (2) | N/M | |||||||||||||||||||||
| Other | 3 | 3 | — | (9 | %) | 4 | 6 | (1) | (25 | %) | |||||||||||||||||||
| Effective tax rate | 24.2 | % | 23.8 | % | 23.4 | % | 23.7 | % | |||||||||||||||||||||
| Net earnings | $ | 56 | $ | 60 | $ | (4) | (7 | %) | $ | 109 | $ | 108 | $ | 1 | 1 | % | |||||||||||||
| Diluted earnings per share | $ | 1.75 | $ | 1.86 | $ | (0.11) | (6 | %) | $ | 3.38 | $ | 3.34 | $ | 0.04 | 1 | % | |||||||||||||
| Twelve-month backlog | $ | 2,490 | $ | 2,500 | $ | (10) | — | % | |||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| (dollars in millions) | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | |||||||||||||||||||||
| Net sales | $ | 270 | $ | 267 | $ | 3 | 1 | % | $ | 518 | $ | 497 | $ | 21 | 4 | % | |||||||||||||
| Operating profit | $ | 33 | $ | 42 | $ | (9) | (22 | %) | $ | 61 | $ | 68 | $ | (6) | (9 | %) | |||||||||||||
| Operating margin | 12.1 | % | 15.8 | % | 11.8 | % | 13.6 | % | |||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| (dollars in millions) | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | |||||||||||||||||||||
| Net sales | $ | 214 | $ | 203 | $ | 11 | 6 | % | $ | 427 | $ | 389 | $ | 39 | 10 | % | |||||||||||||
| Operating profit | $ | 24 | $ | 17 | $ | 7 | 41 | % | $ | 47 | $ | 36 | $ | 10 | 28 | % | |||||||||||||
| Operating margin | 11.1 | % | 8.3 | % | 10.9 | % | 9.4 | % | |||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| (dollars in millions) | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | |||||||||||||||||||||
| Net sales | $ | 216 | $ | 208 | $ | 9 | 4 | % | $ | 437 | $ | 402 | $ | 35 | 9 | % | |||||||||||||
| Operating profit | $ | 26 | $ | 25 | $ | 1 | 3 | % | $ | 50 | $ | 45 | $ | 4 | 10 | % | |||||||||||||
| Operating margin | 11.8 | % | 12.0 | % | 11.4 | % | 11.3 | % | |||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| (dollars in millions) | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | March 29, 2025 | March 30, 2024 | $ Variance | % Variance | |||||||||||||||||||||
| Net sales | $ | 234 | $ | 253 | $ | (19) | (7 | %) | $ | 463 | $ | 500 | $ | (37) | (7 | %) | |||||||||||||
| Operating profit | $ | 27 | $ | 28 | $ | (1) | (3 | %) | $ | 53 | $ | 57 | $ | (4) | (8 | %) | |||||||||||||
| Operating margin | 11.6 | % | 11.1 | % | 11.4 | % | 11.4 | % | |||||||||||||||||||||
| Six Months Ended | |||||||||||
| (dollars in millions) |
March 29,
2025 |
March 30,
2024 |
$ Variance | ||||||||
| Net cash provided (used) by: | |||||||||||
| Operating activities | $ | (93) | $ | 16 | $ | (109) | |||||
| Investing activities | (59) | (84) | 25 | ||||||||
| Financing activities | 152 | 58 | 94 | ||||||||
| Period |
(a) Total
Number of Shares Purchased (1) (2)(3) |
(b) Average
Price Paid Per Share (4) |
(c) Total number
of Shares Purchased as Part of Publicly Announced Plans or Programs (3) |
(d) Maximum Number
(or Approx. Dollar Value) of Shares that May Yet Be Purchased Under Plans or Programs (3) |
||||||||||||||||||||||
| December 29, 2024 - February 1, 2025 | 359,902 | $ | 195.51 | 290,991 | 1,660,107 | |||||||||||||||||||||
| February 2, 2025 - March 1, 2025 | 7,549 | 180.09 | — | 1,660,107 | ||||||||||||||||||||||
| March 2, 2025 - March 29, 2025 | 11,828 | 174.00 | — | 1,660,107 | ||||||||||||||||||||||
| Total | 379,279 | $ | 194.53 | 290,991 | 1,660,107 | |||||||||||||||||||||
| (a) | Exhibits | |||||||||||||
| Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||
| Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||
| Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||||||||
| 101 | Interactive Date files (submitted electronically herewith) | |||||||||||||
| (101.INS) | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||||||||
| (101.SCH) | XBRL Taxonomy Extension Schema Document | |||||||||||||
| (101.CAL) | XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||
| (101.DEF) | XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||
| (101.LAB) | XBRL Taxonomy Extension Label Linkbase Document | |||||||||||||
| (101.PRE) | XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document and are contained within Exhibit 101. | |||||||||||||
| Moog Inc. | |||||||||||||||||
| (Registrant) | |||||||||||||||||
| Date: | April 25, 2025 | By | /s/ Pat Roche | ||||||||||||||
| Pat Roche | |||||||||||||||||
|
Chief Executive Officer
(Principal Executive Officer)
|
|
||||||||||||||||
| Date: | April 25, 2025 | By | /s/ Jennifer Walter | ||||||||||||||
| Jennifer Walter | |||||||||||||||||
|
Chief Financial Officer
(Principal Financial Officer)
|
|
||||||||||||||||
| Date: | April 25, 2025 | By | /s/ Nicholas Hart | ||||||||||||||
| Nicholas Hart | |||||||||||||||||
|
Controller
(Principal Accounting Officer) |
|||||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|